Terlipressin Acetate hmoov CAS 14636-12-5|High Purity Disulfide-Bridged Vasopressin V1 Receptor Agonist Peptide Supplier Tuam Tshoj

Core Muag Cov Ntsiab Lus

✅ Ntau dua lossis sib npaug li 98% HPLC Purity Terlipressin Acetate Powder nrog Batch-Specific COA Muaj

✅ Txheeb xyuas los ntawm HPLC, LC-MS thiab Amino Acid Composition Analysis rau disulfide-cyclized 12-mer peptide kev pom zoo

✅ Tuam Tshoj Peptide Chaw Tsim Tshuaj nrog Fmoc-SPPS Ntau Lawm & GMP-Aligned Quality System

✅ Tshwj xeeb hauv intramolecular disulfide-bond cyclization & cysteine-related impurity tswj

✅ Ua tiav Cov Ntaub Ntawv Pob: COA, HPLC Chromatogram, LC-MS Report & MSDS

✅ Siv tau yooj yim los ntawm Kev Tshawb Fawb Cov Qauv rau Cov Khoom Muag Peptide Thoob Ntiaj Teb

Terlipressin Acetate hmoov yog dab tsi?

Terlipressin Acetate hmoov, tseem hu ua Glycylpressin, yog ib qho disulfide-bridged 12-amino-acid vasopressin analog peptide, ua raws li prodrug metabolized rau active lysine vasopressin.hauv-vivo. Sequence: H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH₂ (Intramolecular disulfide bond ntawm ob Cys residues). Raws li kev xaiv V1 vasopressin receptor agonist, nws txo cov ntshav ntws thiab portal venous siab; dav siv rau portal hypertension, hepatorenal syndrome, vasoactive pharmacology thiab vasopressin receptor qauv-kev ua-kev sib raug zoo kev tshawb fawb.

Tsim los ntawm optimized Fmoc solid-phase peptide synthesis thiab tswj cov kua-theem disulfide cyclization nyob rau hauv peb GMP-zoo system, pebTerlipressin Acetate hmoovnruj me ntsis saib xyuas disulfide mis-pairing impurities, cysteine oxidation (sulfoxide/sulfone), deletion truncates thiab di-sulfide dimer los ntawm-cov khoom, ruaj ruaj V1-receptor-binding bioactivity thiab zoo ib yam batch-to-batch reproducibility. HDM BIO ua haujlwm thoob ntiaj teb biochemistry lub chaw soj nstuam, kws tshuaj R & D cov tuam txhab thiab cov chaw tsim tshuaj lom neeg, suav nrog milligram-theem kev tshawb fawb kuaj txog li kilogram-scale thoob ntiaj teb kev yuav khoom. Cov khoom siv peptide no tsuas yog txwv tsis pub siv rau kev tshawb fawb hauv chav kuaj thiab yuav tsum tsis txhob siv ncaj qha rau tib neeg kev tswj hwm kev kho mob.

Dab tsi yog Cov Lus Qhia Tshwj Xeeb ntawm Terlipressin Acetate Powder?

Txhua pawg tsim khoom ntawm Terlipressin Acetate raug kuaj ntau qib QC suav nrog HPLC, LC-MS thiab cov tshuaj amino acid muaj pes tsawg leeg hauv HDM BIO hauv tsev tshuaj ntsuam xyuas. Batch-specific COA yuav raug muab rau txhua qhov kev txiav txim yuav khoom.

Yam khoom	Specification	Kev tshwm sim
Qhov tshwm sim	Dawb rau tawm -dawb hmoov	Zoo ib yam
Purity (HPLC)	Ntau dua lossis sib npaug li 98%	99.86%
MS Identity	Raws li tus qauv siv	Kev lees paub
Xaus	Cosmetic raw khoom xav tau	Dhau

Terlipressin Acetate vs Related Vasopressin-Tsev Neeg Peptides

Rau cov neeg yuav khoom siv vasopressin-analog raw cov ntaub ntawv rau kev tshawb fawb mob plawv-lub raum ua ntej kev soj ntsuam, cov lus sib piv qhia meej qhov sib txawv tseem ceeb rau kev xaiv cov khoom nyoos:

Khoom	Target Mechanism	Tus yam ntxwv	Daim Ntawv Thov Kev Tshawb Fawb Tseem Ceeb	CAS Nr
Terlipressin Acetate	Selective V1 receptor agonist, prodrug qhib los ntawm peptidase cleavage	12-mer cyclic peptide, N-terminal tri-Gly extension, disulfide nplhaib	Portal hypertension, hepatorenal syndrome ua ntej kev kuaj mob	14636‑12‑5
Lypressin Acetate hmoov	Native Lys-vasopressin, ncaj qha V1/V2 agonist	9-mer cyclic peptide tsis muaj tri-Gly tail	Endogenous vasopressin tswj pawg kev tshawb fawb	50‑57‑7

Tshooj lus no suav nrog cov lus tseem ceeb ntev: terlipressin acetate vasopressin analog raw khoom, glycylpressin tshawb fawb peptide, disulfide-cyclized V1-agonist peptide API.

Yuav Ua Li Cas Thiaj Yuav Terlipressin Acetate Powder los ntawm Lub Tuam Txhab Trustworthy?

Thaum muab khoomTerlipressin Acetate hmoovrau vasopressin-receptor pre-clinical kev tshawb fawb, R & D pab pawg thiab cov neeg yuav khoom thoob ntiaj teb yuav tsum tau soj ntsuam tsib lub ntsiab lus tseem ceeb kom tsis txhob muaj kev pheej hmoo txaus ntshai:

HPLC purity validation: Paub meej ntau dua los yog sib npaug rau 98% HPLC purity nrog batch-specific COA thiab tag nrho impurity chromatogram; them nyiaj tshwj xeeb rau disulfide mis-pairing dimers, Cys-sulfoxide oxidation impurities thiab peptide deletion fragments uas yuav cuam tshuam nrog V1-receptor cell-based kev soj ntsuam
Kev lees paub ntau txoj hauv kev: Peptide tus kheej raug lees paub los ntawm HPLC, LC-MS thiab cov tshuaj amino-acid muaj pes tsawg leeg kom paub meej tias raug tsim intramolecular disulfide-bond cyclic 12-mer peptide
Ua kom tiav batch cov ntaub ntawv pob: lav txhua qhov kev txiav txim tau txais batch-specific COA, HPLC chromatogram, LC-MS daim ntawv qhia thiab MSDS kom txaus siab thoob ntiaj teb ntshuam kev lis kev cai clearance thiab kuaj xyuas cov cai.
Tsim nyog tsim system: Xaiv Tuam Tshoj peptide chaw tsim tshuaj paus nrog mature Fmoc-SPPS workflow thiab GMP-aligned zoo system, pov thawj cov ntaub ntawv ntawm disulfide-bond cyclization thiab cysteine-oxidation impurity suppression technology
Ntiaj teb no saj zawg zog mov: Paub meej tias tus neeg muag khoom tuaj yeem xa ob qho tib si kev tshawb fawb me me thiab ntim loj thoob ntiaj teb kev txiav txim ntau peptide

Terlipressin Acetate Powder Nqe & Daim Ntawv Qhia Ntau Yam 2026

Yog tias koj tab tom nrhiav Terlipressin Acetate hmoov nqe, cov lus hais ntau thiab cov nqe lus xa khoom, thov xa mus rau cov ntaub ntawv tseem ceeb raws li hauv qab no:

Yam tsawg kawg nkaus Order Quantity: Flexible MOQ, milligram & gram-scale tshawb fawb qauv muaj; kilogram-theem thoob ntiaj teb cov khoom lag luam rau kev tshawb fawb txog kev lag luam
Sample Access: Cov qauv tshawb fawb sim rau kev soj ntsuam kuaj; hu rau pab neeg muag khoom kom tau txais cov qauv lus hais
Bulk Kilogram Pricing: Tiered pricing structure; loj bulk ntim coj kev sib tw chav tsev nqi
Lub Sijhawm Ua Haujlwm Ntau Lawm: Kev tuav tshwj xeeb yuav tsum tau ua rau disulfide-cyclized peptide nrog nruj oxidation-tswj cov cai; kev muag khoom yuav lees paub lub sijhawm tsim khoom raws sijhawm raws li kev nug
Shipping Options: kaw txias-pom zoo shipping thoob ntiaj teb; zam lub sijhawm ntev ntawm chav tsev kub; peb muab cov ntaub ntawv ua tiav (batch-specific COA, HPLC chromatogram, LC-MS daim ntawv qhia, MSDS, daim ntawv them nqi lag luam, cov ntawv ntim khoom) rau kev lis kev cai thoob ntiaj teb

Terlipressin Acetate Powder Procurement Guide for Global Buyers

Ua ntej muab cov xaj xaj rau disulfide-cyclized vasopressin-analog peptide raw cov ntaub ntawv, pab pawg neeg yuav khoom thoob ntiaj teb yuav tsum ua tiav cov kauj ruam pov thawj no txhawm rau txo cov kev pheej hmoo:

Tus neeg muab khoom tsim nyog kuaj xyuas: Paub meej tias cov chaw tsim khoom muaj kev ywj pheej peptide-synthesis Rhiav thiab QC lab nrog GMP-txhim kho qhov zoo, kev ua haujlwm ntawm kev ua haujlwm ntawm disulfide-bond cyclization, cysteine-oxidation tswj thiab dimer-impurity sib cais
Kev tshuaj xyuas cov ntaub ntawv: Thov ua ntej xa khoom xa tuaj ua tiav pob ntawv suav nrog batch-specific COA, HPLC chromatogram, LC-MS daim ntawv qhia thiab MSDS; xav tau ntau txoj kev peptide kev lees paub tus kheej thiab impurity profile npog disulfide mis-pairing dimers, Cys-sulfoxide oxidation thiab deletion-truncated impurities
Kev pom zoo ntawm cov khoom: Paub meej tias tus qauv purity, qib endotoxin thiab qhov yuav tsum tau cia txias kom phim koj qhov kev sim tsim; Nco ntsoov cysteine-muaj cyclic peptide yog raug rau huab cua-tsav disulfide rearrangement thiab oxidation tom qab peptide reconstitution
MOQ & lub sij hawm lees paub: Txheeb xyuas cov qauv kev tshawb fawb / cov peptide ntau thoob ntiaj teb muaj, cyclic-peptide ntau lawm voj voog thiab kev txiav txim-kho txoj cai
Shipping-cov ntaub ntawv lees paub: Xyuas kom tus neeg xa khoom tuaj yeem muab cov ntaub ntawv ua tiav los ua kom tau raws li cov kev xav tau ntawm koj cheeb tsam lub hom phiaj

Hais txog HDM BIO Terlipressin Acetate Manufacturing Capability

HDM BIO muaj ntau tshaj 10-xyoo kev txawj ntse nyob rau hauv Fmoc-SPPS peptide synthesis raws li GMP-zoo li system, tshwj xeeb hauv disulfide-bridged cyclic vasopressin-tsev neeg peptide manufacturing nrog meej cyclization-txheej txheem tswj.

Dedicated Fmoc-SPPS cov kab ntau lawm; txais yuav optimized Cys (Acm) orthogonal-tiv thaiv lub tswv yim rau kev tswj cov tshuaj-theem intramolecular disulfide-bond tsim, txo qis intermolecular dimer los ntawm cov khoom lag luam
Kev ywj pheej analytical laboratory nruab nrog HPLC, LC-MS thiab amino-acid muaj pes tsawg leeg tsom xam cov cuab yeej; Tshwj xeeb RP-HPLC gradient workflow rau kev sib cais ntawm disulfide-isomer dimers thiab cysteine-oxidation variants
Peptide cov khoom xa tawm thoob ntiaj teb mus rau ntau dua 70 lub teb chaws, txhawb nqa tsev kawm ntawv labs, biotech startups thiab kws tshuaj R & D lub koom haum
Muaj peev xwm tsim tau txhua xyoo ruaj khov rau kev tshawb fawb-qib peptide raw cov ntaub ntawv, txhawb kev koom tes ua haujlwm ntev
Pab pawg kws tshaj lij tau paub txog hauv vasopressin-tsev neeg peptide-series synthesis, disulfide-cyclization optimization thiab lwm yam kev hloov kho analog.

Dab tsi kev sib tw muaj nyob rau hauv Terlipressin Acetate Synthesis & Production?

Terlipressin Acetate yog 12-mer cyclic peptide nyob rau ntawm qhov raug tsim intramolecular disulfide daim ntawv cog lus ntawm ob cysteine residues. Tswj intermolecular disulfide dimerization, suppressing cysteine sulfoxide/sulfone oxidation impurities thiab tshem tawm deletion-fragment truncates yog ib tug tseem ceeb technical bottlenecks cais cov tsim nyog peptide manufacturers los ntawm cov neeg muag khoom qis.

Cov teeb meem tseem ceeb ntawm kev tsim khoom:

- Ob cysteine residues; Cov xwm txheej tsis raug oxidation yooj yim ua rau cov kab mob sib kis ntawm cov disulfide cross-linking los tsim peptide dimers, uas yog cov qauv zoo sib xws thiab nyuaj rau kev sib cais los ntawm cov pa HPLC.

- Cysteine side-chains yog rhiab heev rau oxidation thaum lub sij hawm cleavage, cyclization, purification thiab lyophilization; cysteine-sulfoxide impurities yuav rhuav tshem lub nplhaib disulfide thiab tshem tawm V1-receptor bioactivity

- N-terminal triple-Gly rov ua ib ntus zoo li tsim cov ntu ntu ntu ntawm kev rho tawm thaum lub sij hawm SPPS coupling cycles; ntau qhov truncated fragments qhia ze HPLC tuav lub sij hawm thiab yog ib qho nyuaj rau lub hauv paus kev sib cais

- Cyclization cov tshuaj tiv thaiv qhov rais yog nqaim; tsis txaus los yog over-oxidation ob qho tib si tsim cov qib siab ntsig txog-cov tshuaj impurities

- Ib qho kev xeem HPLC tsis txaus rau kev txiav txim zoo; multi-validation ntawm HPLC, LC-MS ntxiv rau cov amino-acid muaj pes tsawg leeg tsom xam yog yuav tsum tau lav kom raug-cyclized tag nrho-ntev ntev 12-mer peptide rau vasopressin-receptor functional biology soj ntsuam

Terlipressin Acetate hmoov ua haujlwm li cas hauv Kev Tshawb Fawb Kev Tshawb Fawb?

Raws li hluavtaws disulfide-cyclized vasopressin prodrug peptide,Terlipressin Acetate hmoovyog enzymatically cleavednyob rau hauv vitro / hauv-vivotso tawm nquag lysine-vasopressin, xaiv ua kom vasopressin V1 receptor kom induce splanchnic vasoconstriction thiab txo portal siab. Nws ua haujlwm tseem ceeb hauv kev sim tshuaj reagent rau V1-receptor pharmacology profiling, portal-hypertension tsiaj-model assay, hepatorenal-syndrome pre-clinical ntsuam xyuas thiab vasopressin ligand qauv-kev tshawb nrhiav kev sib raug zoo. Tag nrho cov txheej txheem piav qhia tsuas yog txwv rau hauv vitro thiab pre-clinical tsiaj-kev tshawb fawb scenarios nkaus xwb.

Terlipressin Acetate Powder Ua li cas ntawm HDM BIO?

Terlipressin Acetate yuav tsum muaj kev tswj xyuas tag nrho cov txheej txheem rau cysteine orthogonal tiv thaiv, inert-atmosphere disulfide cyclization, dimer-impurity tshem tawm thiab lyophilization, ua nyob rau hauv peb GMP-zoo system.

Nyeem cov lus qhia ntsig txog: Disulfide-Containing Peptide API Manufacturing Guide|Fmoc SPPS Technology piav qhia

Ua kom tiav Terlipressin Acetate Powder Manufacturing Workflow

Raw-material QC ntawm Fmoc-amino-acid tsev blocks (Cys(Acm) sab-chain tiv thaiv pawg soj ntsuam) → Step-wise 12-mer linear peptide SPPS coupling ntawm cov khoom cob → Resin cleavage & global deprotection ( khaws Cys-Acm orthogonal treude tiv thaiv pawg ) dilute-solution intramolecular disulfide cyclization nyob rau hauv nitrogen cua kom tsis txhob muaj intermolecular dimer tsim → Acm-pab pawg tshem tawm → Multi-theem preparative-HPLC purification (tshem disulfide-dimer isomers, deletion-fragment impurities & cysteine-oxidation impurities) → Acetate- oxidation impurities → lyophilization nyob rau hauv ib puag ncig tsis muaj oxygen → Tag nrho ntau txoj kev QC kuaj (HPLC, LC-MS, amino-acid muaj pes tsawg leeg tsom xam rau kev txheeb xyuas tus kheej, impurity profiling & endotoxin test) → Batch-specific COA muab → Lub teeb-pov thawj, tsis tshua muaj dej ntim ntim hauv qab nitrogen ntxuav

QC Kev Tshawb Fawb Kev Ua Haujlwm

Cov khoom siv raw QC → In-process disulfide-dimer formation risk monitoring → HPLC purity test (cyclic-peptide resolving gradient method for disulfide-isomer separation) → LC-MS molecular-weight & full-sequence verification → Supplementary amino-acid composition analysis for peptide mer-diluted → cysteine-oxidation-impurity quantitative tsom xam → Moisture & heavy-metal test → Residual-solvent & endotoxin detection → Final batch-release approval under GMP-aligned quality system

Cov txheej txheem tseem ceeb

- Orthogonal Cys (Acm) kev tiv thaiv lub tswv yim kom ua tiav qhov chaw tshwj xeeb intramolecular disulfide-bond tsim - Tsawg-concentration dilute-solution cyclization nyob rau hauv inert nitrogen cua los suppress intermolecular peptide dimerization - Optimized RP-HPLC gradient rau hauv paus kev sib cais ntawm disulfide mistruding thiab de-pair-pair High-resolution HPLC rau cais cysteine-sulfoxide oxidation variants thiab muaj feem xyuam rau cyclic-peptide impurities - Multi-level kev lees paub: HPLC, LC-MS ntxiv rau cov amino-acid muaj pes tsawg leeg tsom xam xyuas kom raug-cyclized puv-ntev 12-mer Terlipressin Acetate peptide - Lyophilized khoom ruaj khov nitrogen 2 degree; Tsis txhob rov ua kom khov-thaw mus, rov tsim cov tshuaj peptide yuav tsum tau aliquoted thiab khaws cia ntawm −80 degree, nruj me ntsis tiv thaiv cov qauv ntawm cov pa oxygen.

Dab tsi yog Daim Ntawv Thov Tseem Ceeb ntawm Terlipressin Acetate Powder?

Vasopressin V1 receptor pharmacology tshawb fawb: V1-receptor binding assay, downstream signal-transduction detection, peptidase prodrug-activation stability ntsuam xyuas
Cardiorenal pre-clinical research: Portal-hypertension tsiaj-qauv kev tshawb fawb, hepatorenal-syndrome kev ua tau zoo, kev tshawb nrhiav splanchnic hemodynamics
Vasopressin-tsev neeg peptide kev tshawb fawb sib piv: Ib sab-los-sab kev ua haujlwm sib piv nrog lypressin thiab lwm yam vasopressin analogues
Peptide formulation development: Cyclic-peptide depot-formulation feasibility research, txhaj tshuaj peptide stability-kev tshuaj ntsuam xyuas
Kev npaj Biomedical reagent: Laboratory reference standard for vasopressin-series peptide research
Disulfide-cyclized peptide-process-development research: Orthogonal-tiv thaiv cyclic-peptide synthesis benchmark compound

Vim li cas thiaj xaiv HDM BIO Ua Koj Tus Neeg Siv Khoom Terlipressin Acetate Powder?

- 10+-xyoo Tuam Tshoj-raws li peptide-tsim kev paub nrog Fmoc-SPPS ntau lawm thiab GMP-aligned zoo system

- Tshwj xeeb muaj peev xwm rau complex somatostatin acetate cyclic tetradecapeptide synthesis thiab purification, zoo txo disulfide-mis-pairing isomers, linear txo peptide thiab deletion-fragment impurities

- Txhua batch txhawb nqa los ntawm ntau qhov kev lees paub: HPLC, LC-MS thiab cov ntawv pov thawj disulfide-daim ntawv cog lus, xa nrog cov ntaub ntawv tshwj xeeb ua tiav pob - Ua tiav cov ntaub ntawv tsim khoom tsim tawm-ua raws li Somatostatin Acetate Powder

- Hloov pauv thoob ntiaj teb kev muaj peev xwm: kev tshawb fawb kuaj rau kilogram-scale bulk peptide xaj

- Ntiaj teb no-export kev pab cuam npog ntau tshaj 70 lub teb chaws thoob ntiaj teb - Kev tshaj lij pab neeg txhawb nqa somatostatin-tsev neeg cyclic peptide kev tshawb fawb thiab kev cai-analog synthesis kev sab laj

FAQs Txog Terlipressin Acetate Powder

Q: Kuv puas tuaj yeem yuav Terlipressin Acetate hmoov los ntawm Tuam Tshoj?

A: HDM BIO yog cov chaw tsim khoom hauv Suav teb nrog Fmoc-SPPS ntau lawm thiab GMP-txhim kho qhov zoo, tshwj xeeb hauv disulfide-cyclized vasopressin-analog peptide. Peb muab high-purityTerlipressin Acetate hmoovrau thoob ntiaj teb kws tshuaj R & D pab pawg thiab bioreagent chaw soj nstuam, hloov pauv thoob ntiaj teb los ntawm kev tshawb fawb cov qauv mus rau ntau peptide xaj.

Q: Cov ntaub ntawv dab tsi yuav tsum yog tus neeg tsim nyog Terlipressin Acetate muab?

A: Cov neeg muag khoom ntseeg siab yuav tsum muab cov ntaub ntawv ua tiav: batch-specific COA, HPLC chromatogram, LC-MS report & MSDS. Peptide tus kheej raug txheeb xyuas los ntawm HPLC, LC-MS thiab amino-acid muaj pes tsawg leeg tsom xam;

disulfide-dimer thiab cysteine-oxidation impurity-testing cov ntaub ntawv muaj nyob rau ntawm kev thov.

Q: Tus lej CAS ntawm Terlipressin Acetate Powder yog dab tsi?

A: Tus lej CAS npe ntawm Terlipressin Acetate Powder yog 14636-12-5.

Q: Dab tsi purity qib ntawm Terlipressin Acetate hmoov koj tuaj yeem xa tuaj?

A: Txuj kev tshawb fawb-qib Ntau dua lossis sib npaug rau 98% HPLC purity. Txhua batch los nrog batch-specific COA thiab multi-txoj kev qhia tus kheej validation nrog rau cov amino-acid muaj pes tsawg leeg check. Cov ntsiab lus siab dua-purity thiab vasopressin-series kev cai-peptide-analog synthesis yog muaj rau kev sim tshwj xeeb.

Q: Yuav ua li cas lyophilized Terlipressin Acetate hmoov khaws cia?

A: Khaws ntim rau hauv qhov chaw nitrogen ntawm -20 degree, kom deb ntawm lub teeb, noo noo thiab oxygen. Ua nruj ua tsiv kom tsis txhob rov qab khov-thaw cycles. Aqueous reconstituted tov yog raug rau cysteine oxidation thiab disulfide-bond rearrangement; npaj ib leeg-siv aliquots thiab khaws cia ntawm −80 degree, lub sij hawm ntev cia nyob rau hauv 2-8℃tsis pom zoo.

Q: Kuv puas tuaj yeem tau txais Terlipressin Acetate cov qauv tshawb fawb ua ntej yuav ntau?

A: Yog. Peb muab cov qauv tshawb fawb milligram-rau-gram-theem txuas nrog cov ntaub ntawv ua tiav pob rau kev soj ntsuam hauv chav kuaj.

Q: Dab tsi yog MOQ rau bulk Terlipressin Acetate hmoov xaj thoob ntiaj teb?

A: MOQ yog hloov tau raws li qib purity thiab ntim specifications. Peb txhawb nqa cov qauv tshawb fawb me me thiab cov ntim loj thoob ntiaj teb kev txiav txim siab peptide rau ntau qhov kev xav tau.

Q: Dab tsi yog qhov amino-acid sequence ntawm Terlipressin Acetate Powder?

A: H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH₂, intramolecular disulfide choj ntawm ob cysteine residues.

Kev Tshawb Fawb Txog Kev Tshawb Fawb

Tshuaj xyuas los ntawm:

HDM BIO Peptide Technical Team

Kev txawj ntse:

Fmoc-SPPS peptide synthesis Disulfide-bond-muaj cyclic hormone peptide manufacturing Multi-method peptide characterization: HPLC, LC-MS thiab disulfide-bond verification

Kho tshiab kawg: Lub Yim Hli 2026

Kev lees paub: Tag nrho cov ntsiab lus ntawm cov khoom lag luam ua haujlwm rau kev tshawb fawb kev kawm thiab cov khoom siv raw khoom siv xwb. Tsis yog siv rau tib neeg kev kho mob, kev kuaj mob lossis kev kho mob.